Entity Common Stock, Shares Outstanding of eFFECTOR Therapeutics, Inc. from 31 Oct 2021 to 30 Apr 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
eFFECTOR Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Oct 2021 to 30 Apr 2024.
  • eFFECTOR Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 30 Apr 2024 was 4,704,409, a 89% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

eFFECTOR Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 4,704,409 -37,696,810 -89% 30 Apr 2024 10-Q 09 May 2024 2024 Q1
Q3 2023 64,622,519 +22,729,379 +54% 31 Oct 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 61,765,616 +20,312,826 +49% 31 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 42,401,219 +1,005,857 +2.4% 30 Apr 2023 10-Q 09 May 2023 2023 Q1
Q3 2022 41,893,140 +1,521,414 +3.8% 31 Oct 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 41,452,790 31 Jul 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 41,395,362 30 Apr 2022 10-Q 10 May 2022 2022 Q1
Q3 2021 40,371,726 31 Oct 2021 10-Q 08 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.